Carboxy-ptio, a scavenger of nitric oxide, selectively inhibits the increase in medullary perfusion and improves renal function in endotoxemia

Shock

Volumn 18, Issue 1, 2002, Pages 64-68

  Millar, Colin G M ^a   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acute renal failure; Imidazolineoxyl N oxides; Intrarenal hemodynamics; Sepsis

Indexed keywords

1,3 DIHYDROXY 4,4,5,5 TETRAMETHYL 2 (4 CARBOXYPHENYL)TETRAHYDROIMIDAZOLE; 1,3-DIHYDROXY-4,4,5,5-TETRAMETHYL-2-(4-CARBOXYPHENYL)TETRAHYDROIMIDAZOLE; BENZOIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE; INSULIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ANIMAL; ARTICLE; DRUG EFFECT; ENDOTOXEMIA; HEMODYNAMICS; KIDNEY; KIDNEY CIRCULATION; MALE; METABOLISM; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; RAT; VASCULARIZATION; WISTAR RAT;

ANIMALS; BENZOATES; ENDOTOXEMIA; HEMODYNAMIC PROCESSES; IMIDAZOLES; INSULIN; KIDNEY; LIPOPOLYSACCHARIDES; MALE; NITRIC OXIDE; PERFUSION; RATS; RATS, WISTAR; RENAL CIRCULATION;

EID: 0036636019     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200207000-00012     Document Type: Article

References (35)

1. Cameron JS: Acute renal failure in the ITU: the nephrologist's view. In Bihari D, Neild GH (eds): Acute Renal Failure in the Intensive Therapy Unit. Berlin: Springer-Verlag: 1990, pp 3-12.
2. Rayner BL, Willcox PA, Pascoe MD: Acute renal failure in community acquired bacteraemia. Nephron 54:32-35, 1990.
3. McCarthy JT: Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras. Mayo Clin Proc 71:117-126, 1996.
4. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality: a cohort analysis. J Am Med Assoc 275:1489-1494, 1996.
5. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182:591-595, 1990.
6. Kilbourn RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF: Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophvs Res Commun 172:1132-1138, 1990.
7. Cobb JP, Natanson C, Hoffman WD, Lodato RF, Banks S, Koev CA, Solomon MA, Elin RJ, Hosseini JM, Danner RL: N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176:1175-1182, 1992.
8. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM: Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 129:142-147; discussion 147-148, 1994.
9. Szabo C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472-12476, 1994.
10. Ruetten H, Southan GJ, Abate A, Thiemermann C: Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 118:261-270, 1996.
11. Wray GM, Millar CG, Hinds CJ, Thiemermann C: Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock 9:329-335, 1998.
12. Lieberthal W, Nigam SK: Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol 278:F1-F12, 2000.
13. Denton MD, Chertow GM, Brady HR: "Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int 50:4-14, 1996.
14. Millar CG, Thiemermann C: Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Br J Pharmacol 121:1824-1830, 1997.
15. Thiemermann C: The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 28:45-79, 1994.
16. Schmidt HH, Warner TD, Nakane M, Forstermann U, Murad F: Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages (published erratum appears in Mol Pharmacol 1992 Jul 42:174). Mol Pharmacol 41:615-624, 1992.
17. Green LC, Ruiz de Luzuriaga K, Wagner DA, Rand W, Istfan N, Young VR, Tannenbaum SR: Nitrate biosynthesis in man. Proc Natl Acad Sci USA 78: 7764-7768, 1981.
18. Akaike T, Yoshida M, Miyamoto Y, Sato K, Kohno M, Sasamoto K, Miyazaki K, Ueda S, Maeda H: Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction. Biochemistry 32:827-832, 1993.
19. Maeda H, Akaike T, Yoshida M, Suga M: Multiple functions of nitric oxide in pathophysiology and microbiology: analysis by a new nitric oxide scavenger. J Leukoc Biol 56:588-592, 1994.
20. Pfeiffer S, Leopold E, Hemmens B, Schmidt K, Werner ER, Mayer B: Interference of carboxy-PTIO with nitric oxide- and peroxynitrite-mediated reactions. Free Radic Biol Med 22:787-794, 1997.
21. Yoshida M, Akaike T, Wada Y, Sato K, Ikeda K, Ueda S, Maeda H: Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun 202: 923-930, 1994.
22. Zimmerhackl B, Robertson CR, Jamison RL: The microcirculation of the renal medulla. Circ Res 57:657-667, 1985.
23. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S: Role of nitric oxide in renal medullary oxygenation: studies in isolated and intact rat kidneys. J Clin Invest 88:390-395, 1991.
24. Spain DA, Wilson MA, Garrison RN: Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 116:322-330: discussion 330-331, 1994.
25. Garrison RN, Wilson MA, Matheson PJ, Spain DA: Nitric oxide mediates redistribution of intrarenal blood flow during bacteremia. J Trauma 39:90-96; discussion 96-97, 1995.
26. Pittet JF, Morel DR, Hemsen A, Gunning K, Lacroix JS, Suter PM, Lundberg JM: Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 213:261-264, 1991.
27. Pallone TL, Silldorff EP, Turner MR: Intrarenal blood flow: microvascular anatomy and the regulation of medullary perfusion. Clin Exp Pharmacol Physiol 25:383-392, 1998.
28. Gurbanov K, Rubinstein I, Hoffman A, Abassi Z, Better OS, Winaver J: Differential regulation of renal regional blood flow by endothelin-1. Am J Physiol 271:F1166-F1172, 1996.
29. Kon V, Badr KF: Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 40:1-12, 1991.
30. Ruetten H, Thiemermann C: Effect of selective blockade of endothelin ETB receptors on the liver dysfunction and injury caused by endotoxaemia in the rat. Br J Pharmacol 119:479-486, 1996.
31. Ruetten H, Thiemermann C, Vane JR: Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat. Br J Pharmacol 118:198-204, 1996.
32. Churchill PC, Bidani AK, Schwartz MM: Renal effects of endotoxin in the male rat. Am J Physiol 253:F244-F250, 1987.
33. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 40:632-642, 1991.
34. Heyman SN, Rosen S, Brezis M: Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 2: 153-157, 1994.
35. Myers BD, Carrie BJ, Yee RR, Hilberman M, Michaels AS: Pathophysiology of hemodynamically mediated acute renal failure in man. Kidney Int 18:495-504, 1980.